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Dobrava-Belgrade virus (DOBV) is a European hanta-
virus that causes hemorrhagic fever with renal syndrome 
(HFRS); case-fatality rates in Balkan countries are as high 
as 12%. To determine causative agents, we examined 126 
cases of DOBV-associated HFRS in central and southern 
European Russia. In central Russia (Lipetsk, Voronezh, 
Orel regions), outbreaks were caused by a DOBV variant 
(DOBV-Aa) carried by Apodemus agrarius. In southern 
Russia (Sochi district), where HFRS is endemic, HFRS 
cases were caused by a new DOBV variant (DOBV-Ap), 
found in A. ponticus, a novel hantavirus natural host. Both 
viruses, DOBV-Aa/Lipetsk and DOBV-Ap/Sochi, were iso-
lated through Vero E6 cells, genetically characterized, and 
used for serotyping of the HFRS patients’ serum. The clini-
cal severity of HFRS caused by DOBV-Aa resembles that of 
HFRS caused by Puumala virus (mild to moderate); clinical 
severity of disease caused by DOBV-Ap infections is more 
often moderate to severe.
I
n Russia, the zoonotic virus infection with the highest 
morbidity rate is hemorrhagic fever with renal syndrome 
(HFRS). This disease was ﬁ  rst described in the 1930s as 
hemorrhagic nephroso-nephritis in far eastern Russia and 
Tula fever in European Russia (1). Since 1978, HFRS has 
been included in the ofﬁ  cial reporting system of the Rus-
sian Ministry of Public Health. Annually, 10,000–12,000 
clinical cases of Puumala virus (PUUV) and Dobrava-
Belgrade virus (DOBV) infection, mainly characterized by 
kidney failure, are reported from European Russia. Where-
as PUUV infections predominantly occur in urban areas, 
97% of DOBV-associated HFRS cases occur in rural envi-
ronments (E.A. Tkachenko et al., unpub. data).
The hantaviruses, family Bunyaviridae, that cause 
HFRS are considered emerging viruses because of their 
increasing importance as human pathogens. Hantaviruses 
cause 2 human zoonoses: HFRS in Asia and Europe (caused 
by Hantaan virus [HTNV], Seoul virus [SEOV], PUUV, 
and DOBV) and hantavirus (cardio)pulmonary syndrome 
in the Americas (caused by Sin Nombre and Andes virus-
es) (2–4). Recently, 2 novel hantaviruses, with unknown 
pathogenic potential, were found in Africa (5,6).
Hantaviruses are transmitted by aerosolized excreta 
of their natural hosts, mainly rodents (family Muridae) but 
also shrews (family Soricidae). Particular hantavirus spe-
cies are usually harbored each by a single or a few closely 
related rodent species. The virus genome contains 3 seg-
ments of negative-stranded RNA; the large (L) segment en-
codes viral RNA-dependent RNA polymerase, the medium 
(M) segment encodes glycoprotein precursor, and the small 
(S) segment encodes nucleocapsid protein (4).
DOBV seems to be the most life-threatening hantavi-
rus in Europe; HFRS case-fatality rates are as high as 12% 
in Slovenia and Greece (7,8). DOBV was ﬁ  rst isolated from 
a yellow-necked mouse (Apodemus ﬂ  avicollis) captured in 
a natural focus of HFRS in Dobrava village, Slovenia (9). 
In the 1990s, an outbreak of HFRS in 2 regions of Europe-
an Russia (Tula and Ryazan) was serologically conﬁ  rmed 
to be caused by DOBV, but no clinical characterization of 
the patients was reported (10). In the Tula region, DOBV 
genetic material was detected in A. agrarius (striped ﬁ  eld 
mouse), but not A. ﬂ  avicollis, trapped in Kurkino village, a 
few kilometers from Tula city (11).
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Molecular and serologic evidence indicate that in cen-
tral Europe DOBV is harbored by A. agrarius and causes 
dozens of HFRS cases per year (12–14). This particular 
virus lineage is named DOBV-Aa, and a cell culture iso-
late of DOBV-Aa has been generated (14,15). The severity 
of HFRS caused by DOBV-Aa in central Europe is mild 
to moderate, less severe than its clinical course in Balkan 
countries associated with the DOBV-Af variant hosted by 
A. ﬂ  avicollis (14,16,17).
Another genetic lineage of DOBV was found in the A. 
agrarius species on the Saaremaa island of Estonia, north-
eastern Europe; the Saaremaa virus has been established 
in cell culture (18). Later, these researchers postulated that 
Saaremaa virus should represent its own virus species sepa-
rately from DOBV (19). Recently, 3 HFRS patients have 
been found by serologic approaches to have Saaremaa vi-
rus; however, no molecular (nucleotide sequence) identiﬁ  -
cation of the involved virus strains has been reported (20). 
Detailed phylogenetic analyses show that the strains 
from A. ﬂ  avicollis form a separate evolutionary lineage 
(DOBV-Af) and that strains from A. agrarius show higher 
diversity. Strains from central Europe and European cen-
tral Russia form the DOBV-Aa lineage, which is distinct 
from Saaremaa strains from northeastern Europe (12,15). 
DOBV ecology and evolution have recently become even 
more complex when DOBV was detected in an additional 
rodent host, A. ponticus (Caucasian wood mouse), cap-
tured in Sochi district, in the southern part of European 
Russia (21).
To determine causative agents, we examined 126 
HFRS cases from 2 HFRS-endemic areas of European 
Russia. We isolated the viruses, genetically characterized 
them, and used them for serotyping.
Material and Methods
Patient Selection
During 2000–2006, blood samples from ≈600 patients 
around Sochi who had acute febrile illness with suspected 
hantavirus infection were tested for hantavirus antibody 
by an indirect immunoﬂ  uorescence assay (IFA). Of these, 
26 patients were found to be hantavirus antibody–positive. 
During the HFRS outbreak in the Lipetsk region in the win-
ter of 2001–02, hantavirus infection of >100 patients was 
serologically conﬁ  rmed by IFA as being HFRS.
Rodent Trapping and Screening
Small mammals were trapped in the Sochi region dur-
ing the 3 summer and autumn seasons of 2000–2002 and 
in the Lipetsk region during the winter of 2001–02. Lung 
tissues of the mammals were screened for the presence 
of hantavirus antigens by an antigen-capture ELISA as 
described (22).
Virus Isolation
Suspensions (10%) of ELISA-antigen–positive lungs 
were added to Vero E6 cells as described (23). Then, with 
serum from HFRS patients, the cells were checked for 
hantavirus antigen by IFA. On the 32nd day of passage, 
positive cells were detected in a ﬂ  ask containing cells origi-
nating from an A. agrarius mouse from the Lipetsk region 
(Aa1854/Lipetsk-02 strain [Aa/Lipetsk]) and on the 70th 
day in another ﬂ  ask with cells from an A. ponticus mouse 
from Sochi (Ap1584/Sochi-01 [Ap/Sochi]).
IFA
HFRS patient serum was screened for the presence of 
hantavirus antibody by IFA as described (24); slides with 
combined antigens from Vero E6 cells infected with PUUV, 
DOBV, HTNV, and SEOV were used as substrates. Slides 
with monovalent antigens of these viruses were used for 
serotyping hantavirus antibodies.
Virus Titration and Focus-Reduction 
Neutralization Test
For conﬁ  rmation and serotyping, all IFA-positive se-
rum samples were tested by focus-reduction neutralization 
test (FRNT). The viral stocks, prepared from cell-culture su-
pernatants of infected Vero E6 cells, were titrated with the 
chemiluminescence focus assay (25) or a protein A–peroxi-
dase conjugate/DAB-NiCl2 (26). For FRNT, human conva-
lescent serum samples were diluted serially in 2-fold steps, 
mixed with an equal volume of the respective virus contain-
ing 30–100 focus-forming units of this virus, incubated for 1 
h at 37°C or overnight at 4°C–6°C, and then used to inoculate 
the cells. After 6–10 days of incubation, DOBV-N–speciﬁ  c 
rabbit antiserum or convalescent-phase human serum was 
used to detect the viral antigen as described above. A reduc-
tion in the number of foci of at least 80% was considered as 
the criterion for virus neutralization.
Reverse Transcription–PCR, Cloning, and Sequencing
Hantavirus RNA was extracted from cell-culture 
supernatant by using the QIAamp Viral RNA Mini Kit 
(QIAGEN, Hilden, Germany). The standard QIAamp vi-
ral RNA mini spin protocol was performed. Ampliﬁ  cation 
and sequencing of the entire S and M segments and partial 
L segment sequences were performed as described for the 
DOBV SK/Aa isolate (15).
Sequence and Phylogenetic Analysis
Sequences were aligned by using ClustalW (27). The 
reliability of the alignment was checked by using DotPlot 
(28). The alignment was tested for phylogenetic informa-
tion by likelihood-mapping analysis (29).
We calculated maximum-likelihood and neighbor-
joining phylogenetic trees by using TREE-PUZZLE 5.2 
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(30) and PAUP* 4.0 Beta 10 software packages (31), re-
spectively. The Tamura-Nei and Hasegawa-Kishino-Yano 
evolutionary models with and without gamma distribution 
of rate heterogeneity were used for the tree reconstruc-
tions. We used bootstrap analysis with 10,000 replicates to 
evaluate the statistical signiﬁ  cance of the topology for the 
neighbor-joining trees. Similarity plots and bootscanning 
(32) were performed by using Stuart Ray’s SimPlot 3.2 
with default parameters (33).
Results
HFRS Cases Associated with DOBV Infections
Altogether we characterized 126 patients with DOBV-
associated HFRS (Table 1) from 2 geographically distant 
areas of European Russia. Of these, 108 were from the Li-
petsk region (during 2001–02) and 18 were from the Sochi 
region (sporadic cases during 2000–2006).
In terms of clinical markers, a signiﬁ  cantly higher pro-
portion of the 18 patients from Sochi than from Lipetsk 
had abdominal pain, vision disturbance, nausea and vomit-
ing, diarrhea, hyperemia of the face, hemorrhagic sclerae, 
liver enlargement, oliguria, and anuria; 1 patient died. On 
the other hand, hypertension developed in a signiﬁ  cantly 
higher proportion of the 108 patients from Lipetsk; 1 pa-
tient died (Table 2).
The clinical course of the disease was classiﬁ  ed as 
mild, moderate, or severe, following the standard criteria 
used in the Russian Federation (34). According to these cri-
teria, 55% of the cases in the Sochi region were classiﬁ  ed 
as severe, 39% as moderate, and 6% as mild. In contrast, 
only 27% of the cases in the Lipetsk region were classiﬁ  ed 
as severe, 54% as moderate, and 19% as mild (Table 3).
Association of all investigated HFRS cases with 
DOBV infection was established by IFA serotyping. Anti-
body titers against DOBV, HTNV, SEOV, and PUUV were 
determined. In all cases, antibody titers against PUUV were 
substantially lower. However, for most HFRS cases, IFA 
could not differentiate between DOBV, HTNV and SEOV; 
antibody speciﬁ  cities were ﬁ  nally characterized by FRNT. 
Rodent Trapping and Molecular Identiﬁ  cation
During 2000–2002, an epizootiologic study was per-
formed to identify and isolate the etiologic agents of the 
above-described HFRS cases (21,26). A total of ≈600 small 
animals (8 species) were trapped during 2000–2002 in the 
Sochi region and ≈300 animals (10 species) in the winter of 
2001–2002 in the Lipetsk region. A. ponticus in the Sochi and 
A. agrarius in the Lipetsk region were the species that most 
frequently carried hantavirus antigen; 19.6% and 57.6% of 
animals, respectively, were positive according to ELISA.
To ensure correct classiﬁ  cation of the reservoir hosts, 
tissue samples of the 2 animals that served as the sources 
of virus isolation were subjected to DNA extraction and se-
quence analysis. Nucleotide sequence of the mitochondrial 
DNA fragment containing the control region, D-loop, was 
determined for both animals and compared with Apodemus 
spp. D-loop sequences from GenBank. Neighbor-joining 
phylogenetic analysis demonstrated that the Aa1854/
Lipetsk animal was identiﬁ   ed correctly as A. agrarius. 
However, no A. ponticus D-loop nucleotide sequence 
was available in GenBank for comparison. Nevertheless, 
phylogenetic analysis of Ap1584/Sochi showed that the 
obtained D-loop sequence was distinct from all other ana-
lyzed sequences (Figure 1). This ﬁ  nding at least conﬁ  rms 
that Ap1584/Sochi was not a misidentiﬁ  ed member of A. 
sylvaticus, A. ﬂ  avicollis, or another morphologically simi-
lar Apodemus species.
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Table 1. Characteristics of 126 patients with Dobrava-Belgrade–
associated hemorrhagic fever with renal syndrome, Russia* 
Region, % 
Characteristic
Sochi  (2000–2006), 
n = 18 
Lipetsk (2001–02), 
n = 108 
Sex 
 M  94 66
 F  63 4
Age, y 
<16 12 7
 17–59  88 82
>60 0 11
*Boldface indicates statistically significant differences between groups. 
Comparison of binomial population proportions analysis implemented in 
Statlets (NWP Associates, Inc.; www.mrs.umn.edu/~sungurea/statlets/ 
statlets.htm) indicates that the null hypothesis that the 2 proportions are 
equal could be rejected at significance level of 5.0%. 
Table 2. Clinical signs for 126 patients with Dobrava-Belgrade–
associated hemorrhagic fever with renal syndrome, Lipetsk 
(2001–02) and Sochi (2000–2006) regions, Russia* 
Region, % 
Selected criteria  Sochi, n = 18  Lipetsk, n = 108
Average duration of fever, d  7.1 5.4
Abdominal pain  89 46
Vision disturbance  12 1
Vomiting 72 27
Nausea 89 44
Diarrhea 50 11
Hyperemia of the face  72 29
Hemorrhagic sclerae  50 2
Hypertension  63 4
Liver enlargement  83 23
Oliguria (<500 mL)  77 35
Anuria (<200 mL)  39 8
Increased blood urea and 
creatinine
77 81
Death 5.6 0.9
*Boldface indicates statistically significant differences between groups. 
Comparison of binomial population proportions analysis implemented in 
Statlets (NWP Associates, Inc.; www.mrs.umn.edu/~sungurea/statlets/ 
statlets.htm) indicates that the null hypothesis that the 2 proportions are 
equal could be rejected at significance level of 5.0%. RESEARCH
Sequence Characterization of Virus Isolates
Complete S- and M-segment and partial L-segment nu-
cleotide sequences of both isolates, Sochi/Ap and Lipetsk/
Aa, were determined. The complete S segment of Sochi/
Ap was found to be 1,649 nt long. It contained a single 
open reading frame (ORF; nt 36–1325) that encoded a pu-
tative nucleocapsid protein (N) of 429 amino acids. The 
complete S segment of Lipetsk/Aa was 24 nt longer (1,673 
nt) due to a longer 3′ noncoding region. The Sochi/Ap M 
segment consisted of 3,616 nt that encoded a single ORF 
(nt 47–3448) of putative 1,133-aa glycoprotein precursor. 
The ﬁ  rst putative start codon at positions 41–43, present in 
all other DOBV as well as HTNV M segment sequences, 
was missing, but the next one was located just 6 nt down-
stream in the same frame (as observed also in SEOV M-
segment sequences). The M-segment sequence of Lipetsk/
Aa was 3,643 nt long (ORF positions 41–3448; 1,135 aa); 
the difference in length is again the result of insertions/de-
letions in the 3′ noncoding region. In addition, a partial L-
segment sequence of 541 nt (nt positions 109–649, accord-
ing to the complete L-segment sequence of DOBV AP/Af; 
AJ410617) was determined for the Sochi/Ap and Lipetsk/
Aa strains.
The sequence similarities between the 2 Russian DOBV 
isolates were rather low (Table 4). From the existing DOBV 
cell culture isolates, the Sochi/Ap strain shared the highest 
similarity with AP/Af19 isolate from Greece. Lipetsk/Aa 
virus was most similar to the SK/Aa strain. Between other 
available DOBV sequences, the Sochi/Ap virus S-segment 
sequence was highly similar to a partial sequence found 
in an HFRS patient from Krasnodar (P-s1223/Krasnodar-
2000) as well as to the sequence Ap-1/Goryachiy Klyuch-
2000 ampliﬁ  ed from A. ponticus. (Krasnodar and Gory-
achiy Klyuch are places not far from Sochi.) As expected, 
the Lipetsk/Aa strain was most similar to Kurkino, another 
A. agrarius–associated strain from Russia (Table 4).
Phylogenetic Analysis
Sequences of all 3 segments were analyzed by using 
maximum-likelihood and neighbor-joining phylogenetic 
methods with various evolutionary models. If not otherwise 
stated, all the trees for the particular dataset showed similar 
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Table 3. Severity of clinical disease for 126 patients with Dobrava-Belgrade–associated hemorrhagic fever with renal syndrome, 
Russia*
Severity† 
Characteristic Mild Moderate Severe
Clinical sign or symptom 
  Maximum temperature, °C  <38.0  38.0–39.5  >39.5
  Headache   –/+   +/++   +++/++++ 
  Vision disturbance   –   –/+   +/++ 
  Low-back, abdominal pain   –/+   +/++   +++/++++ 
  Hemorrhagic (petechial) skin rash   –   –/+   –/+/++ 
  Oliguria (minimum mL/d)  >900 300–900 <200–300
  Oliguria duration, d   6 9  11–13 
  Maximum blood urea, mmol/L  <8.3 8.3–19.0 >19.0
 Maximum  blood  creatinine,  ȝmol/L  <130 130–300 >300
  Maximum leukocyte count, 10
9/L <8.0 8.0–14.0 >14.0
Clinical outcome by region  
 Sochi  (2000–2006)  6% 39% 55%
 Lipetsk  (2001–02)  19% 54% 27%
*Boldface indicates statistically significant differences between groups. Comparison of binomial population proportions analysis implemented in Statlets 
(NWP Associates, Inc.; www.mrs.umn.edu/~sungurea/statlets/statlets.htm) indicates that the null hypothesis that the 2 proportions are equal could be 
rejected at significance level of 5.0%. 
†According to Leshchinskaia et al. (34). 
Figure 1. Phylogenetic analysis of D-loop sequences of the animal 
sources of the viruses Sochi/Ap and Lipetsk/Aa (in boldface): 
Apodemus  ponticus from the Sochi region (Ap1584/Sochi; 
EU188455) and A. agrarius from Lipetsk region (Aa1854/Lipetsk; 
EU188456). Sequences of other Apodemus spp. were obtained 
from GenBank; accession numbers are indicated at the branch tips. 
The neighbor-joining tree was constructed by using the Tamura-
Nei (TN93) evolutionary model. Values above the tree branches 
represent the bootstrap values calculated from 10,000 replicates. 
The scale bar indicates an evolutionary distance of 0.1 substitutions 
per position in the sequence.HFRS and Dobrava Hantavirus, Russia
tree topology and statistical support, but only maximum-
likelihood trees with Tamura-Nei evolutionary model are 
shown (Figure 2).
In the S-segment analysis, the Sochi/Ap sequence 
clustered with high statistical support with the patient-
associated sequence from Krasnodar, Russia (AF442623), 
and the A. ponticus–associated sequence from the same re-
gion (AF442622) and formed a distinct lineage, which we 
named DOBV-Ap (Figure 2, panel A). Whereas DOBV-Ap 
and DOBV-Af share a common ancestor in the S-segment 
phylogenetic tree, in M and L segment analysis Sochi/Ap 
formed an outgroup from all other DOBV sequences and 
did not directly cluster with DOBV-Af sequences (Figure 
2, panels B, C). Besides putative genetic reassortment pro-
cesses, incomplete and unequal sequence datasets (fewer 
sequences for M- and L-segment datasets are available) 
could be the reason for these conﬂ  icting results. More se-
quence data are necessary to conﬁ  rm these ﬁ  ndings.
Lipetsk/Aa sequences unambiguously clustered within 
the DOBV-Aa lineage in the analyses of all 3 segments 
(Figure 2, panels A–C). As expected, it formed a well-
supported monophyletic group with DOBV-Aa strains 
from Kurkino, Russia. In M and L segment analysis, for 
which the number of available sequences is rather limited, 
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Table 4. Complete nucleotide and amino acid sequence identities of the Sochi/Ap and Lipetsk/Aa strains of Dobrava-Belgrade virus
compared with currently available cell culture isolates and most related virus sequences of rodent and human origin* 
Sochi/Ap Lipetsk/Aa
S segment  M segment  S segment  M segment 
Virus isolates nt aa nt aa nt aa nt aa
Sochi/Ap – – – – 86.6 96.7 79.7 91.3
Lipetsk/Aa 86.6 96.7 79.7 91.3 – – – –
SK/Aa 84.8 97.4 78.6 90.4 89.9 98.8 87.2 97.0
Slo/Af 87.8 97.6 79.3 93.3 88.5 96.7 82.7 94.0
AP/Af19 87.6 97.9 79.6 93.3 88.2 97.4 82.5 94.1
Saa/160V 84.4 96.2 78.3 90.2 87.5 96.0 86.3 96.2
Kurkino/53Aa/98 86.6 96.7 NA NA 98.8 99.5 NA NA
Ap–1/Goryachiy Klyuch†  96.8 98.8 NA NA 87.3 96.5 NA NA
P–s1223/Krasnodar (patient)†  98.7 99.4 NA NA 86.5 96.4 NA NA
*NA, not available. 
†Values calculated from partial sequences available in GenBank (1,637 bp for Ap–1/Goryachiy Klyuch and 1,196 bp for P–s1223/Krasnodar). 
Figure 2. Maximum-likelihood phylogenetic trees of Dobrava-Belgrade virus (DOBV), showing the phylogenetic placement of novel 
Russian isolates Sochi/Ap and Lipetsk/Aa (in boldface) based on A) complete S-segment open reading frame (ORF) (nucleotide sequence 
positions 36–1325), B) complete M-segment ORF (nt positions 41–3445), and C) partial L-segment sequences (374 nt, positions 157–
530). Different DOBV lineages are marked by colored boxes: yellow, DOBV-Aa; green, Saaremaa; red, DOBV-Af; blue, DOBV-Ap (Sochi 
virus). The Sochi/Ap and Lipetsk/Aa S-, M-, and L-segment sequences were deposited in GenBank under accession nos. EU188449–
EU188454. The trees were computed with the TREE-PUZZLE package by using the Tamura Nei evolutionary model. The values at the 
tree branches are the PUZZLE support values. The scale bar indicates an evolutionary distance of 0.1 substitutions per position in the 
sequence. SANGV, Sangassou virus; HTNV, Hantaan virus; SEOV, Seoul virus; PUUV, Puumala virus; TULV, Tula virus; SNV, Sin Nombre 
virus, ANDV, Andes virus; THAIV, Thailand hantavirus. RESEARCH
DOBV-Aa strains from Slovakia were most closely related, 
although the statistical support for this clustering was be-
low the cutoff value of 70%.
We observed slight differences between maximum-
likelihood and neighbor-joining trees in S segment analy-
sis in which Saaremaa strains clustered with DOBV-Af 
and DOBV-Ap lineages in maximum-likelihood analyses 
but with DOBV-Aa in neighbor-joining analyses. How-
ever, in both instances, the statistical support was below 
the cutoff limit.
Moreover, we performed recombination analyses by 
using similarity plots and bootscanning. However, reliable 
results conﬁ  rming homologous recombination events that 
affected Sochi/Ap or Lipetsk/Aa sequences could not be 
obtained (data not shown).
Serotyping by Using the Novel Virus Isolates
The availability of the 2 novel DOBV strains as cell cul-
ture isolates enabled us to use them in chemiluminescence 
FRNT (c-FRNT) and characterize serum from selected pa-
tients also by neutralizing antibody titers. The DOBV proto-
type strain (Slo/Af; ref.1) and both novel isolates were used 
in c-FRNT to serotype all 18 patients from the Sochi region 
(27 serum samples; consecutive samples available for 8 pa-
tients). For 15 of these 18 patients, at least 1 serum sample 
showed the highest neutralizing antibody titer against the lo-
cal Sochi virus. However, >4-fold differences in titers (con-
sidered to be signiﬁ  cant) were found in serum samples of 
only 10 patients. For 7 patients, such signiﬁ  cant difference 
was not found (5 patients with 2-fold difference, 2 with no 
difference). Table 5 shows examples of convalescent-phase 
serum samples representing these different groups.
From patients in the Lipetsk region, 6 serum samples 
were characterized by c-FRNT (Table 5). To verify whether 
some differences can also be found between 2 DOBV-Aa iso-
lates, DOBV strain SK/Aa isolated in Slovakia, Central Eu-
rope (15), was included in the analysis. Four samples exhib-
ited the highest titer against Lipetsk/Aa when compared with 
Slo/Af and Sochi/Ap, although in only 2 was the difference 
4-fold. One sample reacted equally with Lipetsk/Aa and Slo/
Af, and 1 showed even higher reactivity against the Slo/Af 
strain. When we directly compared Lipetsk/Aa and SK/Aa, 
equal proportions of serum showed equal titers and 2-fold or 
4-fold higher titers against Lipetsk/Aa than against SK/Aa.
In addition, 2 DOBV convalescent-phase serum sam-
ples from Slovakia, previously serotyped as anti–DOBV-
Af reactive (15), were analyzed to determine whether 
Sochi/Ap, Lipetsk/Aa, and Slo/Af could be distinguished 
by these samples. In both instances, Slo/Af virus was neu-
tralized best, although in only 1 case was the difference in 
neutralizing antibody titer 4-fold (Table 5).
Discussion
DOBV circulation was found in the Sochi region, 
southern part of Russia. We demonstrated that a new 
DOBV lineage (DOBV-Ap), associated with A. ponticus 
as a novel natural hantavirus host, was a causative agent of 
the human infection. Second, from an outbreak occurring 
in the Lipetsk region, central European Russia, >100 HRFS 
patients were characterized. This outbreak was found to be 
caused by DOBV-Aa infections. Both viruses, DOBV-Ap/
Sochi and DOBV-Aa/Lipetsk, were isolated through Vero 
E6 cells, genetically characterized, and used for HFRS pa-
tient serotyping.
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Table 5. Results of typing of neutralizing antibodies in serum from patients with Dobrava-Belgrade virus–associated hemorrhagic fever 
with renal syndrome, Russia 
FRNT titer* against
Region Sample no.
Time after onset 
of disease Sochi/Ap Lipetsk/Aa Slo/Af SK/Aa HTNV SEOV PUUV
1,312 104 d 2,560 80 160 ND 160 <80 <40
3,692 30 d 1,280 160 160 ND <80 <80 <40
1,291 16 d 640 160 160 ND 40 40 <40
4,714 1 y, 5 mo >20,480 5,120 5,120 ND 320 320 <40
1,310 50 d 2,560 640 640 ND 160 160 <40
1,307 15 d 640 320 320 ND 160 160 <40
4,716 5 y, 3 mo 5,120 1,280 2,560 ND 160 <80 <40
Sochi
(2000–2006)
4,715 1 y, 4 mo 5,120 2,560 5,120 ND ND ND <40
4,338 6 mo 160 640 160 320 ND† ND† ND†
3,894 21 d 40 640 40 160 ND† ND† ND†
4,334 3 y, 6 mo 160 640 320 160 ND† ND† ND†
4,344 6 mo 160 640 320 640 ND† ND† ND†
3,958 3 mo 20 80 80 40 ND† ND† ND†
Lipetsk
(2001–2002)
4,329 3 y, 4 mo 640 640 2,560 640 ND† ND† ND†
B38 3 y, 9 mo 2,560 640 5,120 2,560 40 640 40 Slovakia
B39 3 y, 9 mo 2,560 1,280 10,240 2,560 160 160 40
*FRNT, focus-reduction neutralization test. Reciprocal end-point titers are given as determined by chemiluminescence FRNT. ND, not determined. 
†Serum previously characterized as anti–Dobrava-Belgrade virus (DOBV) in a first FRNT investigation with Hantaan virus (HTNV), Seoul virus (SEOV), 
Puumala virus (PUUV), and DOBV–Slo/Af only. HFRS and Dobrava Hantavirus, Russia
After the recent detection of DOBV RNA in several A. 
ponticus animals (21), isolation of viable virus can be taken 
as additional evidence that this rodent species represents a 
novel natural hantavirus host. Sequence and phylogenetic 
analysis showed that the strains from A. ponticus form a 
distinct lineage, which we propose to call DOBV-Ap. 
Moreover, clustering of the sequence previously found in 
a specimen from a patient with severe HFRS in Krasnodar 
near Sochi (35) represents ﬁ  nal molecular evidence that 
DOBV-Ap causes HFRS in this region. The Sochi region 
is not yet considered to be a DOBV-associated HFRS-
epidemic or -endemic region. Our ﬁ  ndings therefore have 
some public health importance because this region is inten-
sively used for recreation. DOBV-associated HFRS should 
therefore be considered for travelers returning from this 
region.
The Lipetsk area in Central European Russia is known 
for the DOBV outbreaks that occurred during 1991–1992 
(130 registered cases) and 2001–2002 (167 registered cas-
es, this study). During the winter of 2006–2007, this area 
faced a new large outbreak, which had ≈600 registered 
HFRS cases (authors’ unpub. data).
Serotyping of neutralizing antibodies conﬁ  rmed as rea-
sonable the assumptions that the HFRS cases in the Sochi 
region were caused by DOBV-Ap and that the Lipetsk out-
break was caused by DOBV-Aa strains. In this respect, the 
differences in clinical courses of infection for the Sochi and 
Lipetsk patients could be then also assigned as differences 
in the virulence of DOBV-Ap and DOBV-Aa lineages, 
respectively. Overall, the clinical course of DOBV-Aa in-
fections in Lipetsk resembles that of PUUV infections ob-
served in Russia (authors’ unpub. data), and the DOBV-Ap 
infections seem more often to be moderate to severe.
However, these differences should not be overesti-
mated. Cases in the Lipetsk region occurred in an outbreak 
situation in a region where HFRS is a well-known disease. 
It is therefore possible that physicians and local authori-
ties were much more aware of hantavirus infections and, 
therefore, also recognized those infections with mild clini-
cal courses. In contrast, the sporadic cases in the Sochi re-
gion might be recognized only if the clinical course was 
severe. Differences in physician awareness in the 2 regions 
may result in a bias giving the impression that DOBV-Ap 
infections have a higher clinical severity. Alternatively, 
the higher virulence of DOBV-Ap might correspond with 
its close genetic relatedness with the DOBV-Af lineage, 
which causes rather severe disease in southeastern Europe. 
At the current stage of knowledge, the order of virulence 
of DOBV-like viruses in humans seems to be as follows: 
Saaremaa <DOBV-Aa <DOBV-Ap <DOBV-Af.
Figure 3 shows the regions in Europe where DOBV 
was demonstrated by serologic as well as molecular analy-
ses to be the causative agent of well-characterized HFRS 
cases. Region 1 comprises the Balkan area in southeast-
ern Europe where the classic DOBV (our DOBV-Af) was 
found in A. ﬂ  avicollis animals as well as in human patients 
(7,8). Region 2 encompasses northeastern Germany and 
other regions of central Europe (13,15) as well as the cen-
tral part of European Russia (this study) where the DOBV-
Aa variant from A. agrarius causes mainly mild to moder-
ate HFRS but also severe, life-threatening disease (17). The 
Sochi region, with its novel animal reservoir of DOBV, A. 
ponticus, and the DOBV–Ap- associated HFRS cases is 
marked as region 3. In all these areas, PUUV also circulates 
as an HFRS agent.
In addition to the public health aspect, our ﬁ  ndings 
add another stone into the very complex mosaic of DOBV 
ecology and evolution. The Sochi/Ap virus is the ﬁ  rst cell 
culture isolate of novel evolutionary lineage DOBV-Ap. A. 
ponticus is the third rodent species that should be consid-
ered a natural host of DOBV. Lipetsk/Aa is a new DOBV 
strain isolated on cell culture from A. agrarius (after Saa-
remaa virus from Estonia and SK/Aa from Slovakia) and 
the ﬁ  rst originating from Russia and the ﬁ  rst isolated in an 
outbreak region.
Rather unusual for hantaviruses, DOBV has already 
been found in 3 Apodemus species. Nevertheless, other 
hantaviruses are harbored by >1 (related) host species, e.g., 
Tula virus has been found in Microtus arvalis, M. rossiae-
meridionalis, and M. agrestis (36–38) and SEOV in Rattus 
rattus and R. norvegicus (39). Although the DOBV strains 
from different Apodemus hosts share high amino acid se-
quence similarity, they can be distinguished in phylogenet-
ic analyses as distinct lineages and seem to possess differ-
ent virulence in humans as well as in an animal model (40). 
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Figure 3. Map of Europe showing cases, identiﬁ   ed by serologic 
as well as molecular methods, of hemorrhagic fever with renal 
syndrome caused by infection with the Dobrava-Belgrade virus 
(DOBV) variants: 1,  DOBV-Af; 2, DOBV-Aa ; and 3, DOBV-Ap.RESEARCH
The novel DOBV-Ap lineage associated with A. ponticus 
emerging in an area south of European Russia conﬁ  rms the 
reputation of DOBV being the most virulent of the Euro-
pean hantaviruses.
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